Recipient of federal assistance · OXON HILL, MD

NANOCAN THERAPEUTICS CORPORATION

NANOCAN THERAPEUTICS CORPORATION received $0 in federal grants and other assistance in FY2026, on 3 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2022: $1.8M.

Assistance · FY2026
$0
New awards
0
Actions
3
Since FY2022
$1.8M
UEI
MUW6XWEVLLN3
Businesses

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 799.7KFY2022
  2. 0FY2023
  3. 0FY2024
  4. 998.8KFY2025
  5. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. 93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 24, 2025 – Sep 14, 2026· R42CA268623

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2022–FY2026.